Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Review Article

SRP. 2021; 12(1): 268-271

Evaluation Of Vitamin D Level In Serum Blood Of Rheumatoid Arthritis Patients In Babylon Province

Mustafa Jawad Abed Al Imari, Laith A.I.K. Al-Kaif, Fuad Ghazi Hassan, Saif Anwar Jaafar, Hayder A. A. Al-Asady, Marwa fadhil Alsaffar, Wathiq Essam Hameed, and Ziyad Trik.

Recent studies proofed vitamin D deficiency or insufficiency had been involved in the emerging of many autoimmune diseases like rheumatoid arthritis. The study aim was to evaluate vitamin D3 serum level in RA Babylon province patients and the relationship with BMI and progressive of this disease. A case-control study was conducted in a private OZONE medical center of rheumatology and physical treatment, Babylon province, Iraq. A total of 30 serum samples of Rheumatoid arthritis (RA) cases were enrolled and compared with 30 serum samples of apparently healthy control. The serum level of vitamin D was detected for all study samples by VIDAS® system from bio Mérieux, French. A total of 30 include 11 males and 19(63.4%) females divided into three groups of deficiency sufficiency and insufficiency. The age (years) mean ±SD were 47.7 ±12.06, 47.03 ±12.39 for RA patients and control respectively. The BMI (kg/m2) mean ±SD was 37.08 ±4.6714, 33.506 ±4.6059 for RA and control respectively, and the obesity was significant in RA patients (P=0.004). The number frequency of the two study groups was appeared significant (P< 0.0001, P=0.0003) in both categories; deficiency and normal vitamin D respectively, while insufficient vitamin D did not reveal significant differences between both RA and control. The overall serum level means ±SD was 17.63± 10.61, 33.3±12.73 for RA patient (n=30) and healthy control (n=30) respectively, and appeared high significance (P

Key words: Vitamin D, autoimmune disease, rheumatoid arthritis RA, BMI.

Similar Articles

Exploring the Alzheimer's disease neuroepigenome: recent advances and future trends.
Zhang H, Elefant F
Neural regeneration research. 2022; 17(2): 325-327

Editorial: Novel therapeutic approaches in chronic kidney disease and kidney transplantation: the draw of evolving integrated multimodal approaches in the targeted therapy era.
Tantisattamo E, Hanna RM, Kalantar-Zadeh K
Current opinion in nephrology and hypertension. 2022; 31(1): 1-5

Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson's disease.
Goulding SR, Anantha J, Collins LM, Sullivan AM, O'Keeffe GW
Neural regeneration research. 2022; 17(1): 38-44

Differentiating Human Pluripotent Stem Cells to Vascular Endothelial Cells for Regenerative Medicine, Tissue Engineering, and Disease Modeling.
Bertucci T, Kakarla S, Kim D, Dai G
Methods in molecular biology (Clifton, N.J.). 2022; 2375(): 1-12

Presenilin mutations and their impact on neuronal differentiation in Alzheimer's disease.
Hernandez-Sapiens MA, Reza-Zaldívar EE, Márquez-Aguirre AL, Gómez-Pinedo U, Matias-Guiu J, Cevallos RR, Mateos-Díaz JC, Sánchez-González VJ, Canales-Aguirre AA
Neural regeneration research. 2022; 17(1): 31-37

Full-text options

Latest Statistics about COVID-19
• pubstat.org

Add your Article(s) to Indexes
• citeindex.org

Covid-19 Trends and Statistics
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.

ScopeMed Web Sites